Regeneron Scores Injunctions in Eylea Biosimilar Patent Fight – Bloomberg Law News

Samsung Bioepis Co. was hit with a preliminary injunction in Regeneron Pharmaceuticals Inc.’s patent-infringement lawsuit over proposed …